606% Revenue Growth, But Margin Pressure and Guidance Cuts Tell the Real Story

On the headline numbers TruAlt looks like a runaway success story: ₹811 Cr revenue (606% YoY), ₹35 Cr profit (192% YoY), and a company that went from losses to profitability in a single year. But the quarter tells a different story underneath. Operating margin fell to 12.5% in Q2, down sharply from the ~16% average in the first half. Raw material costs — particularly maize, up 25–30% in Q2 alone due to El Niño supply squeeze — consumed that margin upside. More worrying: management quietly walked back both CBG capex guidance (halved from ₹760 Cr to ₹300 Cr) and ethanol allocation expectations (cut from 44 Cr liters to 40–42 Cr) without explicitly flagging these as revisions. The market has priced in the caution: the stock is down 31.5% from its all-time high, oversold by RSI, and institutional ownership (FII and DII both) has ticked down in the latest quarter.

TruAlt's ethanol business generated approximately ₹750+ Cr in revenue at a blended realization of ₹68–70 per liter — solid in isolation. But the cost base rose faster. Maize, which accounts for a material portion of feedstock costs, jumped 25–30% in Q2 alone as El Niño tightened global grain supply. The company's strategy to absorb this — converting three plants to dual-feed (grain + press mud, rice) and sourcing from lower-cost states like Bihar and Madhya Pradesh — is sensible, but it's a medium-term play. For now, raw material cost as a percentage of sales sat at 62–66% in Q2 and could spike to 70% if inflation remains unabated. That leaves limited room for the 12–14% EBITDA margins management is guiding to, let alone recovery to the 16%+ seen earlier in the year. Management is banking on normalization in Q3–Q4 as raw material prices settle post-El Niño, but offered no quantified guidance on when or by how much margins recover.

Three strategic shifts emerged, none explicitly labeled as reversals: First, CBG capex was quietly halved. Prior guidance called for ₹760 Cr to build 132 TPD of capacity by Q4 FY27. Management now guides to ₹300 Cr for 4–5 plants (~72 TPD visible by Q3 close). Only 20 TPD is commissioned so far, and 3–4 more plants by quarter-end is optimistic given JV complexity with Sumitomo and GAIL. This signals either capex constraints or lower appetite for growth-stage risk. Second, ethanol supply allocation was cut to 40–42 Cr liters for the new supply year (Nov 2026–Oct 2027), down from the 44 Cr liters the company had in hand from the prior call. Government allocation risk is real if OMC demand softens or competing bids rise. Third, SAF (Sustainable Aviation Fuel) timing slipped further. The road map from government is still pending; front-end engineering is ongoing, but no capex or production timeline update. The ₹2,000 Cr capex target and FY29 revenue goal remain untested.

On the positive side, management initiated raw material hedging by converting three plants to grain-base feedstock (press mud, maize, rice instead of sugarcane juice). This diversification is smart, but it's a defense against a problem (RM volatility) that shouldn't exist if hedging contracts were in place. The company is also accumulating inventory at 'cheapest prices,' but with only 8.5 Cr liters of supply locked, the bulk of forward feedstock is at-risk market exposure.

The stock sits at ₹375.75, down 31.56% from its all-time high of ₹549. It trades below all major moving averages (SMA20 ₹430, SMA50 ₹433, SMA200 ₹434) and shows an oversold RSI of 27.8 — typically a capitulation signal. Volume, however, is trending up, suggesting accumulation rather than panic selling. The market's repricing reflects the margin pressure and guidance cuts: growth at any cost is no longer the narrative. Institutional ownership has ticked down: FII fell 8 bps to 0.58% (from 0.66% Q4 FY26), and DII fell 104 bps to 8.36% (from 9.40% Q4). Promoter stake remains stable at 70.55%, signaling no insider alarm. Bulk deal activity tells the story: In June, affiliated entities (DHRUV KHUSH BUSINESS VENTURES) sold large blocks near ₹505–516, reducing exposure at the highs. In September, SIDDHISURI FINVEST accumulated ₹4,73,194 shares at ₹420 — strategic buying at a 23% discount to June levels. Smart money is loading at the lows, but the earnings call gave institutions a legitimate reason to trim. Until margin recovery and CBG execution are proven, the defensive repricing makes sense.